|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Respironics Inc (NASDAQ:RESP), a manufacturer of products serving sleep and respiratory markets. |
|---|---|
| Transferring Party | Apollo Light Systems Inc., a maker of lighting devices to combat seasonal affective disorder. |
| Sector | Medical Devices |
| Date | October 2, 2007 |
| Analysis Expands Respironics into the broader sleep markets (beyond obstructive sleep apnea). Apollo addresses insomnia, circadian rhythm disorders and other sleep/wake market segments. Its products align with Respironics' existing professional sleep clinician and homecare provider channels and reach other channels including researchers in sleep and psychiatry, and practice-based physicians. Deal value - $6.5m based on sales of $5.0m (1.3x) plus earnout. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |